Modulation of tissue factor and thrombomodulin expression in human aortic endothelial cells incubated with high glucose

被引:0
作者
Huang-Joe Wang
Huey-Chun Huang
Yi-Ching Chuang
Pei-Ju Liao
Den-Mei Yang
Wen K. Yang
Haimei Huang
机构
[1] National Tsing Hua University,Institute of Biotechnology
[2] China Medical University Hospital,Division of Cardiology, Department of Medicine
[3] China Medical University,Department of Medical Laboratory Science and Biotechnology
[4] China Medical University Hospital,Laboratory of Cell/Gene Therapy, Department of Medical Research
来源
Acta Diabetologica | 2012年 / 49卷
关键词
Diabetes mellitus; Glucose; Endothelial cells; Tissue factor; Thrombomodulin;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetes is often associated with atherothrombosis. It is unknown whether high glucose can modulate the expression of tissue factor (TF) and thrombomodulin (TM) in human aortic endothelial cells (HAECs). HAECs were treated with a lower-degree high glucose condition (LG, 11.2 mM) for 8 days and a higher-degree high glucose condition (HG, 30 mM) for 4–6 h. Methoxyphenyl tetrazolium inner salt assay, real-time polymerase chain reaction, western blot, and TF activity assay were performed. In HAECs, both LG and HG conditions were nontoxic. LG caused a 74 ± 20% decrease (P = 0.273) and HG caused a 57 ± 5% decrease in TF mRNA expression (P = 0.001). LG caused a 53 ± 13% decrease (P = 0.036) and HG caused a 75 ± 10% decrease in TF protein expression (P = 0.096). TF activity was not significantly changed by LG (127 ± 13%, P = 0.40) or HG treatments (120 ± 42%, P = 0.70). In contrast, LG caused a 153 ± 16% increase (P = 0.03) and HG caused a 211 ± 20% increase in TM mRNA expression (P = 0.005). LG caused a 131 ± 31% increase (P = 0.35) and HG caused a 140 ± 9% increase in TM protein expression (P = 0.006). Different high glucose conditions do not provide the sufficient stress required to induce TF expression in HAECs. In contrast, high glucose conditions can induce TM expression in HAECs.
引用
收藏
页码:125 / 130
页数:5
相关论文
共 113 条
[1]  
Meerarani P(2006)Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications Curr Mol Med 6 501-514
[2]  
Badimon JJ(2004)New aspects in the pathogenesis of diabetic atherothrombosis J Am Coll Cardiol 44 2293-2300
[3]  
Zias E(1997)Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus Exp Clin Endocrinol Diabetes 105 206-212
[4]  
Fuster V(2003)Role of coronary risk factors in blood thrombogenicity and acute coronary syndrome Rev Esp Cardiol 56 1001-1009
[5]  
Moreno PR(2004)Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arter Thromb Vasc Biol 24 816-823
[6]  
Moreno PR(2005)The pathobiology of diabetic complications. A unifying mechanism Diabetes 54 1615-1625
[7]  
Fuster V(2004)Atherothrombosis, a widespread disease with unpredictable and life-threatening consequences Eur Heart J 25 1197-1207
[8]  
Zumbach M(2006)Tissue factor in cardiovascular diseases. Molecular mechanisms and clinical implications Circulation 113 722-731
[9]  
Hofmann M(1989)Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque Proc Natl Acad Sci USA 86 2839-2843
[10]  
Borcea V(1996)Identification of active tissue factor in human coronary atheroma Circulation 94 1226-1232